CYH:NYSECommunity Health Systems, Inc. Analysis
Data as of 2026-06-17 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Community Health Systems (CYH) trades around $3, well below its 20‑day SMA (≈$2.87) and 200‑day SMA (≈$3.17), yet the price remains above the identified support of $2.68, suggesting limited downside cushion. The stock’s PE ratio of 0.87 is dramatically lower than the industry average of 24.3, indicating apparent undervaluation, but this is offset by a negative book value per share and a debt load exceeding $10 bn, which raises balance‑sheet concerns. Technical indicators are mixed: MACD shows a bullish crossover while the overall trend is labeled bearish and volume is decreasing, implying weak buying pressure. Recent news highlights a strategic divestiture of four Arkansas hospitals, signaling a focus on portfolio optimization, but also notes a decline in Adjusted EBITDA, underscoring ongoing earnings pressure. The market sentiment is extremely greedy (Fear & Greed Index 88.5), yet volatility is high at 34% over the past 30 days and beta is above 1.5, reflecting heightened price swings. In this context, CYH appears undervalued from a pure price‑multiple perspective but carries substantial financial and execution risk.
Market Outlook
Short Term
< 1 yearKey Factors
- Price hovering near support with limited upside to resistance
- Decreasing volume indicating weak short‑term demand
- Mixed technical signals (bullish MACD vs bearish trend)
Medium Term
1–3 yearsKey Factors
- Substantially low PE relative to peers suggesting valuation upside
- Strategic asset divestitures aimed at improving cash flow
- Potential upside of ~10% based on upside/downside projection
Long Term
> 3 yearsKey Factors
- Undervalued price metrics if balance‑sheet restructuring succeeds
- Industry demand for acute‑care services providing a stable revenue base
- Long‑term upside potential outweighing current financial strain
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.